Tesamorelin
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to produce endogenous growth hormone while preserving natural pulsatile secretion patterns.
Tesamorelin binds to GHRH receptors, triggering physiological GH release and subsequent IGF-1 production, with a trans-3-hexenoic acid modification that extends half-life from 7 to 26 minutes.
Research demonstrates selective reduction of visceral adipose tissue by 18-47%, originally studied in HIV-associated lipodystrophy but showing broader applications in metabolic optimization.
Studies confirm preservation of natural GH pulsatility unlike direct HGH administration, maintaining endogenous feedback mechanisms while achieving therapeutic effects.
Tesamorelin provides selective visceral fat reduction, preserved endogenous GH rhythms, and metabolic improvements, distinguishing it from other secretagogues through its specific action on abdominal adiposity while maintaining physiological hormone patterns.
Composition: Tesamorelin (5 mg)